4//SEC Filing
PYXIS INNOVATIONS INC 4
Accession 0000950138-12-000330
CIK 0001037649other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:57 PM ET
Size
16.4 KB
Accession
0000950138-12-000330
Insider Transaction Report
Form 4
ALTICOR INC
10% Owner
Transactions
- Other
Series A Preferred Stock
2012-06-29−5,000,000→ 2,535,045 totalExercise: $0.32→ Common Stock (28,160,200 underlying) - Purchase
Convertible Promissory Note
2012-04-13→ 30,695,245 totalExercise: $5.68→ Common Stock (231,804 underlying) - Other
Series A-1 Preferred Stock
2012-06-29+5,000,000→ 30,695,245 totalExercise: $0.32→ Common Stock (28,160,200 underlying)
PYXIS INNOVATIONS INC
10% Owner
Transactions
- Other
Series A Preferred Stock
2012-06-29−5,000,000→ 2,535,045 totalExercise: $0.32→ Common Stock (28,160,200 underlying) - Purchase
Convertible Promissory Note
2012-04-13→ 30,695,245 totalExercise: $5.68→ Common Stock (231,804 underlying) - Other
Series A-1 Preferred Stock
2012-06-29+5,000,000→ 30,695,245 totalExercise: $0.32→ Common Stock (28,160,200 underlying)
Alticor Global Holdings Inc.
10% Owner
Transactions
- Purchase
Convertible Promissory Note
2012-04-13→ 30,695,245 totalExercise: $5.68→ Common Stock (231,804 underlying) - Other
Series A-1 Preferred Stock
2012-06-29+5,000,000→ 30,695,245 totalExercise: $0.32→ Common Stock (28,160,200 underlying) - Other
Series A Preferred Stock
2012-06-29−5,000,000→ 2,535,045 totalExercise: $0.32→ Common Stock (28,160,200 underlying)
SOLSTICE HOLDINGS INC
10% Owner
Transactions
- Purchase
Convertible Promissory Note
2012-04-13→ 30,695,245 totalExercise: $5.68→ Common Stock (231,804 underlying) - Other
Series A Preferred Stock
2012-06-29−5,000,000→ 2,535,045 totalExercise: $0.32→ Common Stock (28,160,200 underlying) - Other
Series A-1 Preferred Stock
2012-06-29+5,000,000→ 30,695,245 totalExercise: $0.32→ Common Stock (28,160,200 underlying)
Footnotes (3)
- [F1]On April 13, 2012, Pyxis was issued a convertible promissory note by the Issuer with an original principal amount of $1,316,255. The maturity date of this convertible promissory note is November 30, 2012. The original principal amount of the convertible promissory note, plus accrued interest thereon, is convertible into the Issuer's common stock at any time at the option of Pyxis. The number of shares of common stock into which the balance of this convertible promissory note may be converted is to be determined by dividing the aggregate principal amount to be converted, together with all accrued interest to the date of conversion, by $5.6783. As of April 13, 2012, the convertible promissory note would have been convertible into 231,804 shares of the Issuer's common stock.
- [F2]This amount includes 5,000,000 shares of the Issuer's Series A-1 preferred stock held by Pyxis, which are convertible into 28,160,200 shares of common stock, as well as shares of common stock issuable upon conversion of multiple promissory notes. As of July 3, 2012, Pyxis holds seven convertible promissory notes issued by the Issuer in the aggregate principal amount of $14,316,255. Taking into account accrued interest to date, these notes are currently convertible into 2,535,045 shares of common stock of Pyxis.
- [F3]Effective June 29, 2012 Pyxis disposed of 5,000,000 shares of the Issuer's Series A preferred stock in exchange for 5,000,000 shares of the Issuer's Series A-1 preferred stock in an exchange agreement between Pyxis and the Issuer. The Series A preferred was convertible into 28,160,200 shares of common stock prior to the exchange. The new Series A-1 preferred stock is convertible 28,160,200 shares of common stock following the exchange, and such conversion right does not expire. The old Series A preferred stock was retired and extinguished in connection with the exchange.
Documents
Issuer
INTERLEUKIN GENETICS INC
CIK 0001037649
Entity typeother
Related Parties
1- filerCIK 0001221575
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:57 PM ET
- Size
- 16.4 KB